Phase
Condition
Dementia
Mental Disability
Memory Loss
Treatment
Alzheimer Disease (AD)
Placebo
Clinical Study ID
Ages 50-85 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Voluntarily participate and have the subject and their legal guardian jointly signthe Informed Consent Form.
The age of the subjects is between 50 and 85 years old.
BMI≥19kg/m2 and ≤32.5 kg/m2, weight ≥45 kg and ≤100 kg at screening or baseline.
Exclusion
Exclusion Criteria:
Cognitive impairment of subjects due to other medical or neurological factors (otherthan AD)
History of stroke or transient ischemic attack, seizures, or other unexplained lossof consciousness within the past year
With any mental illness that may interfere with the cognitive assessment of thesubjects.
With history of moderate or severe renal dysfunction.
With Uncontrolled stable hypertension.
With history of severe trauma or major surgery in the 6 months prior to thescreening period, or planned surgery during the study.
History of malignancy within 5 years prior to screening.
Study Design
Connect with a study center
The First Affiliated Hospital of University of Science and Technology of China
Hefei,
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.